Adeeba Kamarulzaman

Author PubWeight™ 111.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010 3.90
2 The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr 2005 3.18
3 Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis 2009 2.89
4 Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol 2010 2.50
5 High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004 2.41
6 Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet 2010 2.26
7 HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis 2011 2.08
8 Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08_BC and 07_BC in Asia. J Virol 2008 2.07
9 Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr 2006 1.97
10 Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Int J Epidemiol 2010 1.76
11 Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc 2002 1.76
12 Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009 1.76
13 Emerging HIV epidemics in Muslim countries: assessment of different cultural responses to harm reduction and implications for HIV control. Curr HIV/AIDS Rep 2007 1.70
14 Identification of a novel second-generation circulating recombinant form (CRF48_01B) in Malaysia: a descendant of the previously identified CRF33_01B. J Acquir Immune Defic Syndr 2010 1.69
15 Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy 2007 1.65
16 Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007 1.60
17 TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 2011 1.51
18 Malaysia and harm reduction: the challenges and responses. Int J Drug Policy 2007 1.49
19 Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ 2013 1.33
20 Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis 2012 1.30
21 Genome sequence of a novel HIV-1 circulating recombinant form 54_01B from Malaysia. J Virol 2012 1.25
22 Persistent immune activation in chronic HIV infection: do any interventions work? AIDS 2013 1.24
23 Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia. J Virol 2012 1.23
24 Molecular signatures of T-cell inhibition in HIV-1 infection. Retrovirology 2013 1.19
25 Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr 2009 1.16
26 Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend 2013 1.15
27 Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis 2009 1.12
28 Estimating the date of origin of an HIV-1 circulating recombinant form. Virology 2009 1.09
29 Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend 2011 1.09
30 The diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia. PLoS One 2013 1.06
31 Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia. Infect Control Hosp Epidemiol 2002 1.04
32 Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants. Virology 2007 1.04
33 Chronology of the HIV-1 CRF07_BC expansion in East Asia. AIDS 2008 1.03
34 Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse 2010 1.03
35 Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies. Vaccine 2010 1.02
36 Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market. Am J Drug Alcohol Abuse 2009 1.02
37 Prevalence of nosocomial infection and antibiotic use at a university medical center in Malaysia. Infect Control Hosp Epidemiol 2005 1.02
38 Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ 2012 1.02
39 An assessment of health-care students' attitudes toward patients with or at high risk for HIV: implications for education and cultural competency. AIDS Care 2014 0.99
40 Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res 2008 0.98
41 Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb Drug Resist 2004 0.98
42 Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infect Dis 2010 0.97
43 Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia. J Acquir Immune Defic Syndr 2014 0.97
44 Case series of buprenorphine injectors in Kuala Lumpur, Malaysia. Am J Drug Alcohol Abuse 2008 0.96
45 High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. J Infect 2010 0.95
46 Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD. AIDS Res Treat 2012 0.95
47 Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect Dis 2008 0.94
48 Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression. J Acquir Immune Defic Syndr 2015 0.92
49 Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database. J Acquir Immune Defic Syndr 2006 0.92
50 Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia. AIDS 2005 0.91
51 Acute respiratory distress syndrome and acute renal failure from Plasmodium ovale infection with fatal outcome. Malar J 2013 0.91
52 High rates of unprotected anal intercourse with regular and casual partners and associated risk factors in a sample of ethnic Malay men who have sex with men (MSM) in Penang, Malaysia. Sex Transm Infect 2013 0.90
53 Absence of antiretroviral therapy and other risk factors for morbidity and mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One 2012 0.90
54 Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database. J Int AIDS Soc 2012 0.90
55 Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis 2004 0.90
56 The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum Retroviruses 2005 0.89
57 HIV-Mycobacterium tuberculosis co-infection: a 'danger-couple model' of disease pathogenesis. Pathog Dis 2013 0.88
58 Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters. PLoS One 2013 0.87
59 Evolutionary history of HIV-1 subtype B and CRF01_AE transmission clusters among men who have sex with men (MSM) in Kuala Lumpur, Malaysia. PLoS One 2013 0.87
60 Latent tuberculosis infection in a Malaysian prison: implications for a comprehensive integrated control program in prisons. BMC Public Health 2014 0.87
61 Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr 2013 0.86
62 12 myths about HIV/AIDS and people who use drugs. Lancet 2010 0.86
63 Zoonotic Brugia pahangi filariasis in a suburbia of Kuala Lumpur City, Malaysia. Parasitol Int 2010 0.86
64 Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia. J Med Virol 2013 0.85
65 Women and drugs across the globe: a call to action. Int J Drug Policy 2008 0.84
66 Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes. Apoptosis 2015 0.84
67 Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care. J Subst Abuse Treat 2013 0.83
68 Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology 2013 0.83
69 Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection. Front Immunol 2013 0.82
70 Near full-length sequence analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses 2007 0.82
71 Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian Patients. PLoS One 2013 0.81
72 Is there a risk of suburban transmission of malaria in Selangor, Malaysia? PLoS One 2013 0.81
73 Short communication: low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses 2006 0.81
74 Phylodynamic profile of HIV-1 subtype B, CRF01_AE and the recently emerging CRF51_01B among men who have sex with men (MSM) in Singapore. PLoS One 2013 0.80
75 Adapting an Evidence-Based Intervention Targeting HIV-Infected Prisoners in Malaysia. AIDS Res Treat 2011 0.80
76 Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2015 0.79
77 Global Epidemiology of HIV Among Women and Girls Who Use or Inject Drugs: Current Knowledge and Limitations of Existing Data. J Acquir Immune Defic Syndr 2015 0.79
78 Evaluation of the dried blood spot (DBS) collection method as a tool for detection of HIV Ag/Ab, HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral hospital. Ann Acad Med Singapore 2011 0.78
79 Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol 2006 0.78
80 Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia. Genome Announc 2013 0.78
81 Robust interferon-α and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART. Clin Immunol 2011 0.78
82 Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis. Cell Mol Life Sci 2015 0.78
83 Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes 2012 0.78
84 Prevalence of Human Immunodeficiency Virus and Sexually Transmitted Infections Among Cisgender and Transgender Women Sex Workers in Greater Kuala Lumpur, Malaysia: Results From a Respondent-Driven Sampling Study. Sex Transm Dis 2017 0.77
85 Evidence for possible biological advantages of the newly emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and subtype B. Curr HIV Res 2010 0.77
86 Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database. AIDS Patient Care STDS 2015 0.77
87 Isolation and characterization of a replication-competent molecular clone of an HIV-1 circulating recombinant form (CRF33_01B). PLoS One 2009 0.77
88 Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease. Eur J Clin Invest 2015 0.77
89 A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients. Dis Markers 2011 0.77
90 Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia. Biomark Med 2011 0.76
91 Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy. AIDS 2016 0.76
92 Genome Sequence of a Complex HIV-1 Unique Recombinant Form Involving CRF01_AE, Subtype B, and Subtype B' Identified in Malaysia. Genome Announc 2014 0.76
93 Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. J Transl Med 2014 0.76
94 Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific Region. J Antivir Antiretrovir 2009 0.75
95 Response to Birbeck et al. Epilepsia 2008 0.75
96 A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort. J Acquir Immune Defic Syndr 2014 0.75
97 Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. Medicine (Baltimore) 2016 0.75
98 Tenofovir-based antiretroviral therapy in 
HBV-HIV coinfection: results from the TREAT Asia HIV Observational Database. Antivir Ther 2015 0.75
99 Antibiotics in surgical wards: use or misuse? A newly industrialized country's perspective. J Infect Dev Ctries 2015 0.75
100 Transmission Networks of HIV-1 Among Men Who Have Sex With Men in East and Southeast Asia. J Acquir Immune Defic Syndr 2015 0.75
101 Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy. Medicine (Baltimore) 2016 0.75
102 Plasma D-amino acids are associated with markers of immune activation and organ dysfunction in people living with HIV. AIDS 2022 0.75
103 Predictors of death in Malaysian HIV-infected patients on anti-retroviral therapy. Prev Med 2013 0.75
104 Asian public concern over the ethics of scientists: predictors and implications for research ethics. Account Res 2012 0.75
105 Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy. Medicine (Baltimore) 2016 0.75
106 Preface to 'Antiretroviral-based Prevention of HIV'. Sex Health 2014 0.75
107 Tackling infectious diseases threats in the Asia-Pacific through regional and international collaboration. Asia Pac J Public Health 2004 0.75
108 Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia. AIDS 2017 0.75